✅ Guideline Update
ACP Version 2 guidance on breast cancer screening in asymptomatic, average-risk females recommends shared decision-making for ages 40-49, biennial mammography for ages 50-74, and against supplemental MRI or ultrasound for dense breasts. Supplemental DBT may be considered for BI-RADS C or D.
Clinical Considerations
- ACP departs from USPSTF by not recommending routine biennial mammography at age 40, citing harms outweighing marginal mortality benefit in this group
- Annual mammography over 10 years carries a 50% to 60% false-positive rate, reducing future screening adherence
- Overdiagnosis and overtreatment rise with age, particularly in women 70 and older with slow-growing tumors
- Supplemental MRI in dense breasts produced 80 false-positive recalls per 1,000 screened alongside serious adverse event risk
Practice Applications
- Initiate shared decision-making for ages 40-49 and proceed to biennial mammography only if patient prefers screening
- Use biennial mammography as standard for ages 50-74 with average risk
- Discuss discontinuation at age 75 or with limited life expectancy, reassessing every 2 years
- Avoid supplemental MRI and ultrasound in dense breasts; consider supplemental DBT after negative mammography
More Guidelines & Recommendations
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS